NCT00092430View on ClinicalTrials.gov

Study to Evaluate Frozen Versus Refrigerated MMRV (Combined Measles, Mumps, Rubella, and Varicella) Investigational Vaccine (V221-016)

PHASE3CompletedINTERVENTIONAL

Enrollment

1,200

Participants

Timeline

Start Date

September 26, 2002

Primary Completion Date

June 9, 2003

Study Completion Date

June 9, 2003

Conditions

MeaslesMumpsRubellaVaricella

Interventions

BIOLOGICAL

V221, measles, mumps, rubella and varicella (Oka/Merck) virus vaccine live / Duration of Treatment: 12 weeks

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00092430 - Study to Evaluate Frozen Versus Refrigerated MMRV (Combined Measles, Mumps, Rubella, and Varicella) Investigational Vaccine (V221-016) | Biotech Hunter | Biotech Hunter